Stigma and Medical Hesitancy Slow Adoption of Affordable Weight-Loss Drugs in India

Despite monthly prices dropping to around $14, GLP-1 medications face sluggish demand in India due to cultural stigma and cautious prescribing practices among physicians.

28 Aug, 05:06 — 28 Aug, 05:06

Post Share

Sources

Showing 1 of 1 sources

bloombergHigh4h ago

India’s Cheap Weight-Loss Drugs Get A Reality Check

Cheaper weight-loss drugs were expected to take off in India. But despite GLP-1s costing as little as $14 a month, demand has been slower than expected. From stigma to hesitant doctors, Satviki Sanjay explains why price isn’t the only barrier. (Source: Bloomberg)

Read full article →

PERSPECTA

PERSPECTA

Stigma and Medical Hesitancy Slow Adoption of Affordable Weight-Loss Drugs in India

Sources

India’s Cheap Weight-Loss Drugs Get A Reality Check

Related Stories

Inflation Data Strengthens Case for ECB and BOJ Rate Hikes

Markets Await Key Interest Rate Signals From Warsh at Jackson Hole

Venezuela Weighs OPEC Withdrawal as U.S. Relations Improve

French GDP Growth Revised to Zero in Second Quarter

PERSPECTA